
Suspending the NHS medicines repurposing programme in England is a missed opportunity
Ruth E Langley, oncologist1, Gemma Vilahur, cardiovascular researcher23, Mairead Mackenzie, patient representative4, John Burn, geneticist5 1MRC Clinical Trials Unit, University College London, UK 2Research Institute Sant Pau (IR SANT PAU), Barcelona, …